Integration of molecular methods for detection of balanced translocations in the diagnosis and follow-up of patients with leukemia.

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia (2003) 7.04

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia (2003) 4.31

The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer. Ann Oncol (2009) 1.40

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia (2013) 1.27

Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol Cell Biol (1992) 1.16

CPP1, a DNA-binding protein involved in the expression of a soybean leghemoglobin c3 gene. Proc Natl Acad Sci U S A (2000) 1.04

KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer. Br J Cancer (2013) 0.94

Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program. Leukemia (2004) 0.94

Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow. Leukemia (2007) 0.93

A new class of plant homeobox genes is expressed in specific regions of determinate symbiotic root nodules. Plant Mol Biol (1999) 0.92

Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res (1992) 0.91

Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89

Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol (2002) 0.88

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera. Ann Hematol (2008) 0.84

Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leuk Lymphoma (2001) 0.83

Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia. Leukemia (2001) 0.82

A novel type of DNA-binding protein interacts with a conserved sequence in an early nodulin ENOD12 promoter. Plant Mol Biol (1996) 0.81

Identification and cloning of differentially expressed genes by DDRT-PCR. Methods Mol Biol (1997) 0.79

Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia. Eur J Haematol (2003) 0.78

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet. Leukemia (2011) 0.78

Familial Alzheimer's disease co-segregates with a Met146I1e substitution in presenilin-1. Clin Genet (1996) 0.78

[Molecular biology in acute lymphoblastic leukemia]. Ugeskr Laeger (2001) 0.75

A novel MLL-AF10 fusion mRNA variant in a patient with acute myeloid leukemia detected by a new asymmetric reverse transcription PCR method. Leukemia (1997) 0.75

DNA recognition sequence determination directly on plaques of a lambda expressed recombinant DNA binding protein. Anal Biochem (1994) 0.75

[Multidisciplinary diagnostics in acute leukemia]. Ugeskr Laeger (1998) 0.75